Attachment B Federal Registry 60 Day FRN May 2022

15255

Federal Register / Vol. 87, No. 52 / Thursday, March 17, 2022 / Notices
leaders; families (including families
participating in MIECHV-funded home
visiting services and those with shared
experiences); community members,
including community-based program
administrators and community service
providers, including home visitors.
Burden Statement: Burden in this
context means the time expended by

persons to generate, maintain, retain,
disclose, or provide the information
requested. This includes the time
needed to review instructions; to
develop, acquire, install, and utilize
technology and systems for the purpose
of collecting, validating, and verifying
information, processing and
maintaining information, and disclosing

and providing information; to train
personnel and to be able to respond to
a collection of information; to search
data sources; to complete and review
the collection of information; and to
transmit or otherwise disclose the
information. The total annual burden
hours estimated for this ICR are
summarized in the table below.

TOTAL ESTIMATED ANNUALIZED BURDEN HOURS 1
Number of
respondents

Form name

Number of
responses per
respondent

Average
burden per
response
(in hours)

Total
responses

Total burden
hours

Community Interview Protocol .............................................
Family and Community Focus Group Guide .......................
Community and Home Visitor Survey Instrument ...............
Program Data .......................................................................

60
240
500
15

1
1
1
1

60
240
500
15

1.50
2.00
0.75
2.00

90
480
375
30

Total ..............................................................................

815

........................

815

........................

975

1 There

may be variation in the number of study participants and home visiting programs in each community (e.g., some selected communities
may have fewer home visitors). The total burden hours presented here provide information assuming the maximum number of respondents in
each community.

HRSA specifically requests comments
on (1) the necessity and utility of the
proposed information collection for the
proper performance of the agency’s
functions, (2) the accuracy of the
estimated burden, (3) ways to enhance
the quality, utility, and clarity of the
information to be collected, and (4) the
use of automated collection techniques
or other forms of information
technology to minimize the information
collection burden.
Maria G. Button,
Director, Executive Secretariat.
[FR Doc. 2022–05635 Filed 3–16–22; 8:45 am]
BILLING CODE 4165–15–P

DEPARTMENT OF HEALTH AND
HUMAN SERVICES
[Document Identifier: OS–0990–0302]

Agency Information Collection
Request. 60-Day Public Comment
Request
Office of the Secretary, HHS.
Notice.

AGENCY:
ACTION:

In compliance with the
requirement of the Paperwork
Reduction Act of 1995, the Office of the
Secretary (OS), Department of Health

khammond on DSKJM1Z7X2PROD with NOTICES

SUMMARY:

and Human Services, is publishing the
following summary of a proposed
collection for public comment.
DATES: Comments on the ICR must be
received on or before May 16, 2022.
ADDRESSES: Submit your comments to
[email protected] or by calling
(202) 795–7714.
FOR FURTHER INFORMATION CONTACT:
When submitting comments or
requesting information, please include
the document identifier 0990–0302 and
project title for reference, to Sherrette A.
Funn, email: [email protected],
or call (202) 795–7714 the Reports
Clearance Officer.
SUPPLEMENTARY INFORMATION: Interested
persons are invited to send comments
regarding this burden estimate or any
other aspect of this collection of
information, including any of the
following subjects: (1) The necessity and
utility of the proposed information
collection for the proper performance of
the agency’s functions; (2) the accuracy
of the estimated burden; (3) ways to
enhance the quality, utility, and clarity
of the information to be collected; and
(4) the use of automated collection
techniques or other forms of information
technology to minimize the information
collection burden.

Title of the Collection: Medical
Reserve Corps Unit Profile and Reports.
Type of Collection: Revision.
OMB No.: 0990–0302.
Abstract: Medical Reserve Corps
Units are currently located in 748
communities across the United States
and represent a resource of over 300,000
volunteers. In order to continue to
support MRC units, detailed
information about the MRC units,
including unit/user demographics,
contact information, volunteer numbers
and information about non-emergency
and emergency unit activities is needed
by the MRC Program. MRC Unit Leaders
are asked to update this information on
the MRC website at least quarterly and
to participate in a technical assistance
assessment using the Capability
Assessment and Factors for Success at
least annually. This collection informs
resources and tools developed as part of
national programing and helps to
identify trends and target technical
assistance to support MRC units’
preparedness to respond to disasters in
their communities. The MRC unit data
collection has been refined to eliminate
duplication and streamline data
collection tools.

ANNUALIZED BURDEN HOUR TABLE
Forms
(if necessary)

Respondents
(if necessary)

Unit Profile ........................................
Capability Assessment ......................
Factors for Success ..........................

MRC Unit Leader .............................
MRC Unit Leader .............................
MRC Unit Leader .............................

VerDate Sep<11>2014

17:38 Mar 16, 2022

Jkt 256001

PO 00000

Frm 00065

Number of
respondents

Fmt 4703

Sfmt 4703

Number of
responses per
respondents

748
748
748

E:\FR\FM\17MRN1.SGM

4
1
1

17MRN1

Average
burden per
response
15/60
30/60
30/60

Total
burden hours
748
374
374

15256

Federal Register / Vol. 87, No. 52 / Thursday, March 17, 2022 / Notices
ANNUALIZED BURDEN HOUR TABLE—Continued

Unit Activity Reporting ......................

MRC Unit Leader .............................

748

4

15/60

748

Total ...........................................

...........................................................

........................

10

........................

2,244

[FR Doc. 2022–05612 Filed 3–16–22; 8:45 am]
BILLING CODE 4150–47–P

DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Office of the Secretary
Findings of Research Misconduct
Office of the Secretary, HHS.
Notice.

AGENCY:
ACTION:

Findings of research
misconduct have been made against
Shuo Chen, Ph.D. (Respondent),
formerly a postdoctoral researcher,
Department of Physics, University of
California, Berkeley (UCB). Respondent
engaged in research misconduct in
research reported in a grant application
submitted for U.S. Public Health Service
(PHS) funds, specifically National
Institute of Neurological Disorders and
Stroke (NINDS), National Institutes of
Health (NIH), grant application K99
NS116562–01. The administrative
actions, including supervision for a
period of one (1) year, were
implemented beginning on February 28,
2022, and are detailed below.
FOR FURTHER INFORMATION CONTACT:
Wanda K. Jones, Dr.P.H., Acting
Director, Office of Research Integrity,
1101 Wootton Parkway, Suite 240,
Rockville, MD 20852, (240) 453–8200.
SUPPLEMENTARY INFORMATION: Notice is
hereby given that the Office of Research
Integrity (ORI) has taken final action in
the following case:
Shuo Chen, Ph.D., University of
California, Berkeley: Based on the report
of an investigation conducted by UCB
and additional analysis conducted by
ORI in its oversight review, ORI found
that Dr. Shuo Chen, formerly a
postdoctoral researcher, Department of
Physics, UCB, engaged in research
misconduct in research reported in a
grant application submitted for PHS
funds, specifically NINDS, NIH, grant
application K99 NS116562–01.
ORI found that Respondent engaged
in research misconduct by intentionally,
knowingly, and/or recklessly falsifying
SUMMARY:

khammond on DSKJM1Z7X2PROD with NOTICES

Average
burden per
response

Respondents
(if necessary)

Sherrette A. Funn,
Paperwork Reduction Act Reports Clearance
Officer, Office of the Secretary.

VerDate Sep<11>2014

17:38 Mar 16, 2022

Jkt 256001

Number of
respondents

Number of
responses per
respondents

Forms
(if necessary)

data and methods by altering, reusing,
and relabeling source two-photon
microscopy and electrophysiological
data to represent images of mouse
hippocampal neurons in the following
grant application:
• K99 NS116562–01, ‘‘Investigation
into network dynamics of hippocampal
replay sequences by ultrafast voltage
imaging,’’ submitted to NINDS, NIH, on
June 25, 2019.
ORI found that Respondent
intentionally, knowingly, and/or
recklessly falsified two-photon
microscopy and in vivo
electrophysiological activity images,
figure legends, and text descriptions of
hippocampal neurons from a mouse
running on a treadmill in a head-fixed
virtual reality (VR) set up. Specifically:
• Respondent reused an image of
visual cortex neurons to represent
fluorescence calcium imaging of
hippocampal neurons in Figure 6d and
its associated text and figure legend of
K99 NS116562–01.
• Respondent reused in vivo
electrophysiological data from control
mice of spatial receptive fields for all
recorded place cells during linear track
exploration sessions from Supplemental
Figure 1b from Nat Neurosci. 2018
Jul;21(7):996–1003 (doi: 10.1038/
s41593–018–0163–8) to represent
several sessions of two-photon
hippocampal calcium imaging of
progressive place fields, obtained from
multiple mice running on a treadmill in
a head-fixed VR set up, in Figure 6e and
its associated text and figure legend of
K99 NS116562–01.
Respondent neither admits nor denies
ORI’s findings of research misconduct.
The parties entered into a Voluntary
Settlement Agreement (Agreement) to
conclude this matter without further
expenditure of time, finances, or other
resources. The settlement is not an
admission of liability on the part of the
Respondent.
Respondent voluntarily agreed to the
following:
(1) Respondent will have his research
supervised for a period of one (1) year
beginning on February 28, 2022 (the
‘‘Supervision Period’’). Prior to the
submission of an application for PHS
support for a research project on which

PO 00000

Frm 00066

Fmt 4703

Sfmt 4703

Total
burden hours

Respondent’s participation is proposed
and prior to Respondent’s participation
in any capacity in PHS-supported
research, Respondent will submit a plan
for supervision of Respondent’s duties
to ORI for approval. The supervision
plan must be designed to ensure the
integrity of Respondent’s research.
Respondent will not participate in any
PHS-supported research until such a
supervision plan is approved by ORI.
Respondent will comply with the
agreed-upon supervision plan.
(2) The requirements for Respondent’s
supervision plan are as follows:
i. A committee of 2–3 senior faculty
members at the institution who are
familiar with Respondent’s field of
research, but not including
Respondent’s supervisor or
collaborators, will provide oversight and
guidance during the Supervision Period.
The committee will review primary data
from Respondent’s laboratory on a
quarterly basis and submit a report to
ORI at six (6) month intervals setting
forth the committee meeting dates and
Respondent’s compliance with
appropriate research standards and
confirming the integrity of Respondent’s
research.
ii. The committee will conduct an
advance review of each application for
PHS funds, or report, manuscript, or
abstract involving PHS-supported
research in which Respondent is
involved. The review will include a
discussion with Respondent of the
primary data represented in those
documents and will include a
certification to ORI that the data
presented in the proposed application,
report, manuscript, or abstract is
supported by the research record.
(3) During the Supervision Period,
Respondent will ensure that any
institution employing him submits, in
conjunction with each application for
PHS funds, or report, manuscript, or
abstract involving PHS-supported
research in which Respondent is
involved, a certification to ORI that the
data provided by Respondent are based
on actual experiments or are otherwise
legitimately derived and that the data,
procedures, and methodology are
accurately reported in the application,
report, manuscript, or abstract.

E:\FR\FM\17MRN1.SGM

17MRN1